Concord Wealth Partners Viatris Inc Transaction History
Concord Wealth Partners
- $603 Million
- Q4 2024
A detailed history of Concord Wealth Partners transactions in Viatris Inc stock. As of the latest transaction made, Concord Wealth Partners holds 2,717 shares of VTRS stock, worth $30,647. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,717
Previous 2,726
0.33%
Holding current value
$30,647
Previous $31,000
6.45%
% of portfolio
0.01%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding VTRS
# of Institutions
1,095Shares Held
965MCall Options Held
2.69MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA141MShares$1.59 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.05 Billion0.02% of portfolio
-
State Street Corp Boston, MA63.1MShares$712 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$707 Million4.18% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD48.8MShares$550 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $13.7B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...